Testing effectiveness (Phase 2)Study completedNCT00054015What this trial is testing3-AP in Treating Patients With Advanced Prostate CancerWho this might be right forProstate Cancer Vion Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT00566332What this trial is testingTrial Comparing Chlorambucil to Fludarabine in Patients With Advanced Waldenström MacroglobulinemiaWho this might be right forWaldenström MacroglobulinemiaLymphoplasmacytic LymphomaSplenic Marginal Zone Lymphoma French Study Group on Chronic Lymphoid Leukemia 414
Not applicableUnknownNCT06205732What this trial is testingA Retrospective Study on the Treatment of Intermediate and Advanced Liver Cancer.Who this might be right forCarcinoma, Hepatocellular Qianfoshan Hospital 100
Testing effectiveness (Phase 2)Ended earlyNCT00868114What this trial is testingDirect Tumor Injection KLH-Pulsed Dendritic Cells in Unresectable Pancreatic CancerWho this might be right forMetastatic Pancreatic Cancer Leo W. Jenkins Cancer Center 24
Large-scale testing (Phase 3)Looking for participantsNCT06675214What this trial is testingUnder Whole-course of Immunotherapy, Gradient Fractionated RT with CCT Versus CFRT with CCT for LANPC Who Achieved PR Post Induction Chemotherapy.Who this might be right forNasopharyngeal CarcinomaDe-escalation Therapy Sun Yat-sen University 586
Early research (Phase 1)Looking for participantsNCT06764316What this trial is testingA First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver CancerWho this might be right forHepatocellular Carcinoma Bayer 148
Testing effectiveness (Phase 2)Ended earlyNCT06924606What this trial is testingEvaluating the Preliminary Efficacy and Safety of JS207 in NSCLC After Progression Following Platinum-based Chemotherapy and ImmunotherapyWho this might be right forAdvanced NSCLC Shanghai Junshi Bioscience Co., Ltd. 18
Early research (Phase 1)Ended earlyNCT02367352What this trial is testingAlisertib (MLN8237) in Combination With Weekly Paclitaxel in East Asian Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsOvarian CancerSmall Cell Lung Cancer Millennium Pharmaceuticals, Inc. 9
Testing effectiveness (Phase 2)Study completedNCT04212052What this trial is testingSplit-course Hypofractionated Radiotherapy With Concurrent Chemotherapy in Locally Advanced Non-small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Sun Yat-sen University 104
Testing effectiveness (Phase 2)Study completedNCT00151047What this trial is testingDocetaxel Plus Capecitabine in Newly Diagnosed Localized or Locally Advanced Prostate CancerWho this might be right forProstate Cancer University of Michigan Rogel Cancer Center 15
Not applicableStudy completedNCT05487248What this trial is testingOn-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer PatientsWho this might be right forUnresectable Locally Advanced Colorectal CancerMetastatic Colorectal CancerCandidate for Third-line or Subsequent Lines of Therapy Jules Bordet Institute 103
Testing effectiveness (Phase 2)Active Not RecruitingNCT06717126What this trial is testingA Randomised Phase II Study of Roginolisib in Patients With Advanced/Metastatic Uveal MelanomaWho this might be right forUveal MelanomaOcular Melanoma iOnctura 85
Testing effectiveness (Phase 2)Ended earlyNCT01215578What this trial is testingPredictive Biomarkers of Response to Sunitinib in the Treatment of Poorly-differentiated NEURO-Endocrine TumorsWho this might be right forNeuroendocrine TumorsPancreatic NeoplasmsAdvanced Disease+1 more Assistance Publique - Hôpitaux de Paris 33
Testing effectiveness (Phase 2)UnknownNCT00149578What this trial is testingA Phase II Study of Combine Modality Therapy in Locally Advanced Pancreatic CancerWho this might be right forPancreatic Cancer National Health Research Institutes, Taiwan 45
Not applicableStudy completedNCT01649778What this trial is testingObservational Study of Real World Effectiveness Data and Safety in Patients Receiving Pazopanib With Advanced or Metastatic Renal Cell CarcinomaWho this might be right forCarcinoma, Renal Cell Novartis Pharmaceuticals 662
Testing effectiveness (Phase 2)UnknownNCT02942563What this trial is testingTotal Neoadjuvant Therapy for Locally Advanced Rectal CancerWho this might be right forRectal Cancer RenJi Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00193414What this trial is testingPemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung CancerWho this might be right forLung Cancer SCRI Development Innovations, LLC 72
Testing effectiveness (Phase 2)Study completedNCT05963984What this trial is testingSamuraciclib in Combination With Fulvestrant in Metastatic or Locally Advanced Breast Cancer in Adult ParticipantsWho this might be right forMetastatic Breast CancerLocally Advanced Breast CancerBreast Cancer Carrick Therapeutics Limited 60
Early research (Phase 1)Looking for participantsNCT06393738What this trial is testingARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.Who this might be right forRelapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL)Relapsed/Refractory (R/R) Angioimmunoblastic T-cell Lymphoma (AITL) Arvinas Inc. 329
Large-scale testing (Phase 3)Not Yet RecruitingNCT07340658What this trial is testingInvestigate the Efficacy and Safety of Letrozole SIE Compared With Femara® (Both Combined With the CDK4/6 Inhibitor Ribociclib) in Postmenopausal Women With HR-Positive, HER2-Negative, Inoperable Locally Advanced or Metastatic Breast CancerWho this might be right forAdvanced, Metastatic Breast Cancer Rovi Pharmaceuticals Laboratories 300